Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes.

Paudel, Sanjita; Jo, Hyoje; Lee, Taeho; Lee, Sangkyu

Paudel, Sanjita; Jo, Hyoje; Lee, Taeho; Lee, Sangkyu.

Afiliación

Paudel S; BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Jo H; BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Lee T; BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea.
Lee S; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.

Biopharm Drug Dispos ; 44(5): 365-371, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37448189

Asunto(s)

Citocromo P-450 CYP1A2; Microsomas Hepáticos; Humanos; Citocromo P-450 CYP1A2/metabolismo; Citocromo P-450 CYP1A2/farmacología; Microsomas Hepáticos/metabolismo; Inhibidores Enzimáticos del Citocromo P-450/farmacología; Fenacetina/farmacología; Fenacetina/metabolismo; Sistema Enzimático del Citocromo P-450/metabolismo

Palabras clave

CYP1A2; competitive inhibition; human liver microsomes; reversible inhibitor; suberosin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microsomas Hepáticos / Citocromo P-450 CYP1A2 Límite: Humans Idioma: En Revista: Biopharm Drug Dispos Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google